Lotus Bio Technology Development Stock Today
| LBTD Stock | USD 0.01 0.00 0.00% |
PerformanceWeakest
| Odds Of DistressSmall
|
Lotus Bio-Technology is trading at 0.01 as of the 1st of February 2026, a No Change since the beginning of the trading day. The stock's lowest day price was 0.01. Lotus Bio-Technology has about a 44 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 3rd of November 2025 and ending today, the 1st of February 2026. Click here to learn more.
Lotus Bio-Technology Development Corp., a bio-technology development company, focuses on refining organic materials, and production of natural consumer related products in China. Lotus Bio-Technology Development Corp. was founded in 2011 and is based in Cave Creek, Arizona. The company has 782.77 M outstanding shares. More on Lotus Bio Technology Development
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Lotus Pink Sheet Highlights
| President CEO, Director | Zoltan Nagy |
| Business Concentration | Consumer Discretionary, Media (discontinued effective close of September 28, 2018), Agricultural Inputs, Basic Materials (View all Sectors) |
Lotus Bio Technology Development [LBTD] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.78 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lotus Bio-Technology's market, we take the total number of its shares issued and multiply it by Lotus Bio-Technology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Lotus Bio Technology conducts business under Media (discontinued effective close of September 28, 2018) sector and is part of Consumer Discretionary industry. The entity has 782.77 M outstanding shares.
Lotus Bio Technology Development currently holds about 1 in cash with (17.75 K) of positive cash flow from operations.
Check Lotus Bio-Technology Probability Of Bankruptcy
Ownership AllocationLotus Bio Technology maintains a total of 782.77 Million outstanding shares. Lotus Bio Technology Development secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 60.4 % of Lotus Bio Technology Development outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Lotus Ownership Details
Lotus Stock Against Markets
Lotus Pink Sheet Analysis Notes
About 60.0% of the company outstanding shares are owned by corporate insiders. The company had not issued any dividends in recent years. Lotus Bio Technology had 30:1 split on the 26th of June 2014. Lotus Bio-Technology Development Corp., a bio-technology development company, focuses on refining organic materials, and production of natural consumer related products in China. Lotus Bio-Technology Development Corp. was founded in 2011 and is based in Cave Creek, Arizona. Lotus Bio-Technology is traded on OTC Exchange in the United States.The quote for Lotus Bio Technology Development is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Lotus Bio Technology Development contact Zoltan Nagy at 480-275-2294 or learn more at www.lotusbiotechnologies.com.Lotus Bio Technology Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more pink sheets at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Lotus Bio-Technology's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Lotus Bio Technology Development or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Lotus Bio Technology generated a negative expected return over the last 90 days | |
| Lotus Bio Technology has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (19.55 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Lotus Bio Technology Development currently holds about 1 in cash with (17.75 K) of positive cash flow from operations. | |
| Roughly 60.0% of the company outstanding shares are owned by corporate insiders |
Lotus Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.78 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lotus Bio-Technology's market, we take the total number of its shares issued and multiply it by Lotus Bio-Technology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Lotus Bio Technology, as well as the relationship between them.Lotus Bio Technology Price Movement Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Lotus Bio Technology Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Lotus Bio-Technology price patterns.
Lotus Bio-Technology Outstanding Bonds
Lotus Bio-Technology issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Lotus Bio Technology uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Lotus bonds can be classified according to their maturity, which is the date when Lotus Bio Technology Development has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Lotus Bio-Technology without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
| All Next | Launch Module |
Other Information on Investing in Lotus Pink Sheet
Lotus Bio-Technology financial ratios help investors to determine whether Lotus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lotus with respect to the benefits of owning Lotus Bio-Technology security.